Welcome to LookChem.com Sign In|Join Free
  • or
DL-Normetanephrine is a chemical compound that serves as an intermediate in the synthesis of various pharmaceuticals, particularly in the production of certain drugs used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is a derivative of norepinephrine, a neurotransmitter that plays a crucial role in the regulation of attention, alertness, and arousal. DL-Normetanephrine is synthesized through a series of chemical reactions, often involving the reduction of the corresponding ketone, metanephrine, followed by methylation. The compound is typically used in a racemic mixture, meaning it contains equal amounts of both the dextrorotatory (D) and levorotatory (L) enantiomers. Its importance lies in its role as a precursor in the manufacturing process of certain medications, highlighting its significance in the pharmaceutical industry.

97-31-4

Post Buying Request

97-31-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97-31-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97-31-4 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 97-31:
(4*9)+(3*7)+(2*3)+(1*1)=64
64 % 10 = 4
So 97-31-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3

97-31-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-Amino-1-hydroxyethyl)-2-methoxyphenol

1.2 Other means of identification

Product number -
Other names DL-normethanephrine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:97-31-4 SDS

97-31-4Relevant academic research and scientific papers

3-methoxy-4-hydroxyphenylglycol fluorescence polarization immunoassay

-

, (2008/06/13)

The present invention is directed to a fluoroescence polarization immunoassay for determining the 3-methoxy-4-hydroxyphenylglycol content in body fluids, to the various components needed for preparing and carrying out such an assay, and to methods of making these components. Specifically, tracers, immunogens and antibodies are disclosed, as well as methods for preparing them. The assay is conducted by measuring the degree of polarization of plane polarized light that has been passed through a sample containing antiserum and tracer.

SYNTHESIS OF 3-O-METHYLATED DERIVATIVES OF CATECHOLAMINES

Kulikov, S. V.,Samartsev, M. A.

, p. 280 - 288 (2007/10/02)

3-O-Methylated catecholamines, used in the radioenzyme method for the analysis of catecholamines in blood, were synthesized. The optimum conditions for the production of both the intermediate and the final products were determined. By the use of tetrabutylammonium bromide in the condensation of nitromethane with O-benzylvanilin it is possible to obtain a high yield of 1-(3-methoxy-4-benzyloxyphenyl)-2-nitroethanol. The latter is easily transformed at a palladium catalyst into methylnoradrenaline by reduction with ammonium formate. The reduction of 1-(3-methoxy-4-benzyloxyphenyl)-2-nitroethylene with hydrogen or its donors at a palladium catalyst takes place significantly more readily in the presence of ferric chloride.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 97-31-4